Written and maintained by CASRAI Editorial Board
Last updated
The NIHR Invention for Innovation (i4i) programme is a UK-specific funding scheme most research-administration content treats as a footnote in a broader survey of National Institute for Health and Care Research (NIHR) funding — a single bullet point alongside dozens of other programmes. That framing understates what i4i actually is: a dedicated translational funding stream for medical devices, in vitro diagnostic devices, and digital health technologies, distinct in structure, eligibility, and process from both the project-grant and career-fellowship funding covered in CASRAI’s general guide to NIHR funding. For a research administrator or technology-transfer professional supporting a health-technology investigator or spinout, knowing i4i’s specific structure — not just that it exists — is the difference between correctly scoping an application and missing a fit.
What i4i funds
i4i funds collaborative research and development projects aimed at medical devices, in vitro diagnostic devices, and high-impact patient-focused digital health technologies intended for use in the NHS or social care systems. The defining eligibility criterion is stage: i4i is not an early-discovery fund. Applicants must already have demonstrated proof of concept and be able to show a clear pathway toward regulatory clearance, adoption, and commercialisation. This positions i4i squarely in the “translational” gap between university proof-of-concept work and full commercial development — the same gap CASRAI’s technology readiness level (TRL) framework is built to describe.
The three i4i funding streams
As of the current NIHR programme structure, i4i runs three distinct funding streams, each with its own scope and cadence:
- Product Development Awards (PDA) — the programme’s core, researcher-led stream, funding the development of a specific device or diagnostic technology through to a defined commercialisation or adoption milestone.
- Connect — a stream restricted to UK-based small and medium enterprises (SMEs), designed to support company-led development rather than an academic-led project.
- FAST (Funding At the Speed of Translation) — a commissioned (rather than researcher-led) stream, used for time-limited, NIHR-defined priorities; a 2026 FAST call, for example, targeted real-world integration of preventive technologies into community-care settings such as Neighbourhood Health Hubs and Community Diagnostic Centres.
NIHR runs roughly three researcher-led opportunities (PDA and Connect) and two commissioned opportunities (FAST) per year, rather than keeping a single fund open on a rolling basis — a research office tracking i4i needs to watch for discrete competition windows, not assume year-round eligibility.
Who can apply
Eligibility differs by stream. For PDA and FAST, eligible applicants include UK-based higher education institutions, small and medium enterprises, NHS or social-care providers, not-for-profit organisations, and local authorities and governments — a broader applicant pool than most NIHR schemes, reflecting that device and diagnostic development routinely spans university, NHS, and commercial partners in a single project. Connect, by contrast, is restricted to UK-based SMEs only. In practice this means a university spinout applying under Connect must itself meet the SME definition, while the same spinout collaborating with its parent university on device development would apply under PDA instead — a distinction worth confirming with i4i’s programme team ([email protected]) before choosing a route.
Governance and how funding decisions are made
i4i funding decisions run through dedicated i4i funding committees, distinct from the committees reviewing NIHR’s clinical-trial or fellowship applications. These multidisciplinary committees combine clinical, scientific, and commercialisation expertise specifically because i4i applications are assessed on both scientific merit and a credible pathway to adoption — a dual bar that a standard NIHR programme-grant application, assessed on scientific merit alone, does not have to clear.
How i4i fits into the wider NIHR and UK innovation-funding landscape
i4i sits alongside, and is frequently sequenced with, other UK translational-funding routes covered elsewhere in CASRAI’s Dictionary and guides. A device programme that starts with university IP protection and a provisional patent application, proceeds through i4i for translational development, and later engages the NHS’s wider innovation-adoption infrastructure follows a recognisable UK pathway. For research administrators managing that pathway end to end, i4i is the funding mechanism that specifically bridges proof-of-concept and commercial readiness for devices and diagnostics — a role no other NIHR programme is structured to fill.
Frequently asked questions
Is i4i the same as an NIHR research grant?
No. i4i is a dedicated translational programme for medical devices, in vitro diagnostics, and digital health technologies specifically, requiring existing proof of concept and a commercialisation pathway. General NIHR research-project funding, by contrast, does not require a product-development stage or a commercial endpoint. See CASRAI’s broader NIHR funding guide for how i4i relates to the full NIHR programme portfolio.
Can a company apply to i4i on its own, without a university or NHS partner?
Under the Connect stream, yes — Connect is restricted to UK-based SMEs and does not require an academic or NHS co-applicant. Under PDA and FAST, a wider range of applicant types is eligible, including SMEs, but the eligible-applicant list also includes universities, NHS/social-care providers, and non-profits, so a collaborative bid is common though not mandatory.
What stage does a technology need to be at before applying?
i4i requires demonstrated proof of concept and a clear pathway toward regulatory clearance and adoption or commercialisation. It is not intended for early discovery-stage research; applicants without proof-of-concept data are generally better matched to an earlier-stage funder.
How often does i4i open for applications?
NIHR typically runs around three researcher-led opportunities (PDA and Connect combined) and two commissioned opportunities (FAST) per year, rather than a single continuously open call — check NIHR’s current funding-opportunities listing for live competition dates before assuming a route is open.
